Check-Cap Ltd (F:7CC) — Market Cap & Net Worth
Market Cap & Net Worth: Check-Cap Ltd (7CC)
Check-Cap Ltd (F:7CC) has a market capitalization of $8.64 Million (€7.39 Million) as of June 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #27414 globally and #2375 in its home market, demonstrating a 4.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Check-Cap Ltd's stock price €1.20 by its total outstanding shares 7020502 (7.02 Million). Review 7CC current and long-term liabilities to assess the company's total debt and financial obligations.
Check-Cap Ltd Market Cap History: 2015 to 2026
Check-Cap Ltd's market capitalization history from 2015 to 2026. Data shows change from $3.39 Billion to $9.85 Million (-44.82% CAGR).
Check-Cap Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Check-Cap Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7CC by Market Capitalization
Companies near Check-Cap Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to Check-Cap Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Check-Cap Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Check-Cap Ltd's market cap moved from $3.39 Billion to $ 9.85 Million, with a yearly change of -44.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €9.85 Million | -13.04% |
| 2025 | €11.33 Million | +36.63% |
| 2024 | €8.29 Million | -47.67% |
| 2023 | €15.84 Million | +2.34% |
| 2022 | €15.48 Million | -83.74% |
| 2021 | €95.21 Million | +111.68% |
| 2020 | €44.98 Million | -81.97% |
| 2019 | €249.51 Million | -10.06% |
| 2018 | €277.42 Million | -79.59% |
| 2017 | €1.36 Billion | -68.19% |
| 2016 | €4.27 Billion | +26.03% |
| 2015 | €3.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Check-Cap Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.64 Million USD |
| MoneyControl | $8.64 Million USD |
| MarketWatch | $8.64 Million USD |
| marketcap.company | $8.64 Million USD |
| Reuters | $8.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Check-Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.